Companies: 10,795·Total market cap: $144.5T
VectivBio Holding AG

VectivBio Holding AG

VECTNASDAQHealthcare
$16.87
+$0.02(+0.12%)
Market Cap$1.1B
P/E Ratio
52W High$16.98
52W Low$4.25
Overview

VectivBio Holding AG (VECT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

vect · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for VectivBio Holding AG (VECT) measures how much investors pay for each dollar of the company's trailing earnings. VECT's current PE ratio of N/A is calculated by dividing its stock price of $16.87 by its TTM earnings per share of -$2.12.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
EPS (TTM)
-$2.12
TTM · diluted EPS
PEG Ratio
-0.08
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · VectivBio Holding AG SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2018 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
VectivBio Holding AG
VectivBio Holding AGYou
VECT
$1.1BN/A-$2.12
Albireo Pharma, Inc.
Albireo Pharma, Inc.
ALBO
$916MN/A-$7.87
Crescent Biopharma, Inc.
Crescent Biopharma, Inc.
CBIO
$476MN/A-$14.78
Chimerix, Inc.
Chimerix, Inc.
CMRX
$801MN/A-$0.99
CTI BioPharma Corp.
CTI BioPharma Corp.
CTIC
$1.2BN/A-$0.79
EQRx, Inc.
EQRx, Inc.
EQRX
$1.1B5.68x$0.43
Ethzilla Corp.
Ethzilla Corp.
ETHZ
$56MN/A-$5517.71

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-2.12
2021-12-31
FY2021
$-3.23
2020-12-31
FY2020
$-2.40
2019-12-31
FY2019
$-1.01
2018-12-31
FY2018
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for VectivBio Holding AG (VECT) measures how much investors pay for each dollar of the company's trailing earnings. VECT's current PE ratio of N/A is calculated by dividing its stock price of $16.87 by its TTM earnings per share of -$2.12.

PE Ratio = Stock Price ÷ EPS (TTM)
= $16.87 ÷ -$2.12 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

VECT pe ratio · 6 questions

VECT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $16.87 and TTM EPS of -$2.12. Data sourced from Financial Modeling Prep via VECT's SEC 10-K and 10-Q filings.

VECT PE ratioWhat is VECT PE ratioCurrent PE ratio of VECTVECT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · VectivBio Holding AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09